A new pill could be the future of treatment late-stage pancreatic cancer in the U.S., nearly doubling the length patients ...

Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.

When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that challenged the traditional research model.

Researchers have found that amlodipine, a calcium-channel blocker prescribed to tens of millions of people for high blood pressure, can strip a key immune-evasion protein from the surface of cancer ...

Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, often driven by abnormal lipid metabolism and excessive blood vessel growth. In a new study, researchers from Fudan ...

UIC researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes. Their work appears in the journal Drug Resistance Updates. "This opens ...

Neuroscientists at King's College London have pinpointed a mechanism behind the increased neural connectivity observed in the very early stages of Alzheimer's disease. Published in Translational ...